|

CivaDerm(TM) Surface Therapy Pilot Study

RECRUITINGEarly 1Sponsored by CivaTech Oncology
Actively Recruiting
PhaseEarly 1
SponsorCivaTech Oncology
Started2024-05-01
Est. completion2025-12-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04480645

Summary

This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* subject signed informed consent
* Confirmed superficial or nodular basal cell or squamous cell carcinoma
* Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
* \>5 mm of residual tumor
* tumors \< 3 cm
* Capable of complying with Patient Release Instructions

Exclusion Criteria:

* Is unable or unwilling to comply with the protocol requirements
* Pregnant or breast feeding
* Metastases

Conditions3

Basal Cell CarcinomaCancerSquamous Cell Carcinoma of the Skin

Locations1 site

CivaDerm Oncology PLLC
Morrisville, North Carolina, 27560
Carra Castagnero9193145515ccastagnero@civatechoncology.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.